Department of Defense – pre-announcement of the Spinal Cord Injury Research Program, FY19

April 2, 2019 by School of Medicine Webmaster

The Department of Defense has released pre-announcements for the Spinal Cord Injury Research Program managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP) to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.

FY19 funding opportunities are anticipated for the following SCIRP programs:

Clinical Trial Award

  • Independent investigators at all academic levels (or equivalent).
  • Preproposal is required; application submission is by invitation only.
  • Funds Phase 0, I, or II clinical trials with the potential to have a major impact on treatment or management of spinal cord injury (SCI) and its consequences.
  • Applications must include at least two SCI consumer advocates as members of the research team.
  • Preclinical data required for all clinical trial applications.
  • Maximum funding of $3M for direct costs (plus indirect costs) for a period of 4 years.

Investigator-Initiated Research Award

  • Independent investigators at all academic levels (or equivalent).
  • Preproposal is required; application submission is by invitation only.
  • Funds SCI-related research that has the potential to make an important contribution to SCI research and/or patient care.
  • Preliminary data required.
  • Clinical trials not allowed.
  • Maximum funding of $500,000 for direct costs (plus indirect costs) over a period of 3 years.

Translational Research Award

  • Independent investigators at all academic levels (or equivalent).
  • Preproposal is required; application submission is by invitation only.
  • Funds studies that accelerate the movement of promising ideas in SCI research into clinical applications.
  • Applications must include at least one SCI consumer advocate as a member of the research team.
  • Preliminary data required.
  • The SCIRP TRA may include a pilot clinical trial as part of the proposed research where limited clinical testing of a novel intervention or device is necessary to inform the next step in the continuum of translational research.
  • Maximum funding of $1.25M for direct costs (plus indirect costs) over a period of 3 years.

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcement.  FY19 pre-announcements can be found in the CDMRP home page features at https://cdmrp.army.mil.

Subsequent notifications will be sent when the program announcements/funding opportunities are released.

Filed Under: Funding Opportunities